Clinical data

95% in High Risk Bladder Cancers

Such as High Risk Non-Muscle Invasive Bladder Cancers (NMIBC)  and Muscle Invasive Bladder Cancer (MIBC)


Voided urine specimens were obtained from 578 patients, presenting with haematuria and/or lower urinary tract symptoms at 6 leading UK hospitals.
Urine samples were processed per the ADXBLADDER Instructions For Use.
Patient data was collected and cystoscopy, imaging and biopsy results were compared to the ADXBLADDER result.

NPV of 97%

Upper Tract Sensitivity 80%

80% sensitivity for Upper Tract Transitional Cell Carcinomas (TCCs) such as those of the Ureters and Kidney, which can be difficult to detect with cystoscopy or ultrasound.